Streetbeat News

Products Services

ORGS

Orgenesis Inc. announced positive results from a real-world study of its ORG-101 CAR-T therapy, showing high complete response rates in both adult and pediatric patients with CD19+ Acute Lymphoblastic Leukemia. The study also indicated a favorable safety profile with low incidence of severe Cytokine Release Syndrome. Harley Street Healthcare Group plans to collaborate with Orgenesis to establish a Global Cancer Initiative to further develop and democratize advanced therapies.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 12:32 pm

AFRM

BCDA

LUCY

BioCardia, Innovative Eyewear, and Affirm see significant stock price increases. BioCardia's rise follows FDA clearance for a new product, Innovative Eyewear benefits from a new sales channel, and Affirm reports strong earnings and guidance.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 12:24 pm

VIK

Viking has announced six new itineraries in Asia, expanding access to Japan and China, including Tibet in 2025. These voyages, ranging from 15 to 22 days, will offer exclusive access to destinations in China and Japan, with bookings now open.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 12:17 pm

LUCY

Innovative Eyewear's stock is rising as their Lucyd Lyte frames are now available on Target.com, potentially increasing sales and market reach.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 12:14 pm

JNJ

Johnson & Johnson has submitted a Biologics License Application to the FDA for nipocalimab, a treatment for generalized myasthenia gravis. This marks the first FDA submission for nipocalimab, based on successful Phase 3 trial results.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 12:13 pm

MODG

Topgolf is set to open a new venue in Greensboro, North Carolina, on September 13, 2024. This will be the fourth Topgolf location in the state, joining others in Charlotte and Durham.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 12:12 pm

OTRK

Ontrak, Inc. (NASDAQ:OTRK) has partnered with MosaicVoice to enhance healthcare delivery and patient outcomes using AI-powered voice technology. This strategic partnership aims to create a more connected and patient-centric healthcare ecosystem.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 12:11 pm

RLYB

Rallybio Corporation announced the publication of Phase 1 study results for RLYB212, a monoclonal antibody aimed at preventing alloimmunization and FNAIT. The study showed promising results, and a Phase 2 trial is planned for late 2024.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 12:09 pm

SNAL

Snail, Inc. (NASDAQ:SNAL) announces a major Steam Publisher Sale from August 29 to September 4, 2024, offering discounts on top titles. Historically, these sales have boosted unit sales by 520% compared to non-promo periods, enhancing revenue and player engagement.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 12:08 pm